Reuters logo
BRIEF-Pieris Pharmaceuticals reports Q3 loss per share $0.16
November 8, 2017 / 10:11 PM / a month ago

BRIEF-Pieris Pharmaceuticals reports Q3 loss per share $0.16

Nov 8 (Reuters) - Pieris Pharmaceuticals Inc

* Pieris Pharmaceuticals reports financial results for the third quarter ended september 30, 2017, and provides corporate update

* Q3 loss per share $0.16

* Pieris Pharmaceuticals Inc - ‍cash and equivalents totaled $89.9 million as of September 30, 2017, compared to $29.4 million as of December 31, 2016​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below